The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans

Bas J. Blaauboer, Kim Boekelheide, Harvey J. Clewell, Mardas Daneshian, Milou M L Dingemans, Alan Goldberg, Marjoke Heneweer, Joanna Jaworska, Nynke I. Kramer, Marcel Leist, Hasso Seibert, Emanuela Testai, Rob J. Vandebriel, James D Yager, Joanne Zurlo

Research output: Contribution to journalArticle

Abstract

The role that in vitro systems can play in toxicological risk assessment is determined by the appropriateness of the chosen methods, with respect to the way in which in vitro data can be extrapolated to the in vivo situation. This report presents the results of a workshop aimed at better defining the use of in vitro-derived biomarkers of toxicity (BoT) and determining the place these data can have in human risk assessment. As a result, a conceptual framework is presented for the incorporation of in vitro-derived toxicity data into the risk assessment process. The selection of BoT takes into account that they need to distinguish adverse and adaptive changes in cells. The framework defines the place of in vitro systems in the context of data on exposure, structural and physico-chemical properties, and toxicodynamic and biokinetic modeling. It outlines the determination of a proper point-of-departure (PoD) for in vitro-in vivo extrapolation, allowing implementation in risk assessment procedures. A BoT will need to take into account both the dynamics and the kinetics of the compound in the in vitro systems. For the implementation of the proposed framework it will be necessary to collect and collate data from existing literature and new in vitro test systems, as well as to categorize biomarkers of toxicity and their relation to pathways-of-toxicity. Moreover, data selection and integration need to be driven by their usefulness in a quantitative in vitro-in vivo extrapolation (QIVIVE).

Original languageEnglish (US)
Pages (from-to)411-425
Number of pages15
JournalAltex
Volume29
Issue number4
StatePublished - 2012

Fingerprint

Biomarkers
In Vitro Techniques
Toxicology
Education

Keywords

  • Biomarker of toxicity
  • Integrated testing strategies
  • Quantitative in vitro-in vivo extrapolations

ASJC Scopus subject areas

  • Medical Laboratory Technology
  • Pharmacology

Cite this

Blaauboer, B. J., Boekelheide, K., Clewell, H. J., Daneshian, M., Dingemans, M. M. L., Goldberg, A., ... Zurlo, J. (2012). The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. Altex, 29(4), 411-425.

The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. / Blaauboer, Bas J.; Boekelheide, Kim; Clewell, Harvey J.; Daneshian, Mardas; Dingemans, Milou M L; Goldberg, Alan; Heneweer, Marjoke; Jaworska, Joanna; Kramer, Nynke I.; Leist, Marcel; Seibert, Hasso; Testai, Emanuela; Vandebriel, Rob J.; Yager, James D; Zurlo, Joanne.

In: Altex, Vol. 29, No. 4, 2012, p. 411-425.

Research output: Contribution to journalArticle

Blaauboer, BJ, Boekelheide, K, Clewell, HJ, Daneshian, M, Dingemans, MML, Goldberg, A, Heneweer, M, Jaworska, J, Kramer, NI, Leist, M, Seibert, H, Testai, E, Vandebriel, RJ, Yager, JD & Zurlo, J 2012, 'The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans', Altex, vol. 29, no. 4, pp. 411-425.
Blaauboer BJ, Boekelheide K, Clewell HJ, Daneshian M, Dingemans MML, Goldberg A et al. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. Altex. 2012;29(4):411-425.
Blaauboer, Bas J. ; Boekelheide, Kim ; Clewell, Harvey J. ; Daneshian, Mardas ; Dingemans, Milou M L ; Goldberg, Alan ; Heneweer, Marjoke ; Jaworska, Joanna ; Kramer, Nynke I. ; Leist, Marcel ; Seibert, Hasso ; Testai, Emanuela ; Vandebriel, Rob J. ; Yager, James D ; Zurlo, Joanne. / The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. In: Altex. 2012 ; Vol. 29, No. 4. pp. 411-425.
@article{20d31c12437549daa099071fbbabddf7,
title = "The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans",
abstract = "The role that in vitro systems can play in toxicological risk assessment is determined by the appropriateness of the chosen methods, with respect to the way in which in vitro data can be extrapolated to the in vivo situation. This report presents the results of a workshop aimed at better defining the use of in vitro-derived biomarkers of toxicity (BoT) and determining the place these data can have in human risk assessment. As a result, a conceptual framework is presented for the incorporation of in vitro-derived toxicity data into the risk assessment process. The selection of BoT takes into account that they need to distinguish adverse and adaptive changes in cells. The framework defines the place of in vitro systems in the context of data on exposure, structural and physico-chemical properties, and toxicodynamic and biokinetic modeling. It outlines the determination of a proper point-of-departure (PoD) for in vitro-in vivo extrapolation, allowing implementation in risk assessment procedures. A BoT will need to take into account both the dynamics and the kinetics of the compound in the in vitro systems. For the implementation of the proposed framework it will be necessary to collect and collate data from existing literature and new in vitro test systems, as well as to categorize biomarkers of toxicity and their relation to pathways-of-toxicity. Moreover, data selection and integration need to be driven by their usefulness in a quantitative in vitro-in vivo extrapolation (QIVIVE).",
keywords = "Biomarker of toxicity, Integrated testing strategies, Quantitative in vitro-in vivo extrapolations",
author = "Blaauboer, {Bas J.} and Kim Boekelheide and Clewell, {Harvey J.} and Mardas Daneshian and Dingemans, {Milou M L} and Alan Goldberg and Marjoke Heneweer and Joanna Jaworska and Kramer, {Nynke I.} and Marcel Leist and Hasso Seibert and Emanuela Testai and Vandebriel, {Rob J.} and Yager, {James D} and Joanne Zurlo",
year = "2012",
language = "English (US)",
volume = "29",
pages = "411--425",
journal = "ALTEX : Alternativen zu Tierexperimenten",
issn = "1868-596X",
publisher = "Elsevier GmbH",
number = "4",

}

TY - JOUR

T1 - The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans

AU - Blaauboer, Bas J.

AU - Boekelheide, Kim

AU - Clewell, Harvey J.

AU - Daneshian, Mardas

AU - Dingemans, Milou M L

AU - Goldberg, Alan

AU - Heneweer, Marjoke

AU - Jaworska, Joanna

AU - Kramer, Nynke I.

AU - Leist, Marcel

AU - Seibert, Hasso

AU - Testai, Emanuela

AU - Vandebriel, Rob J.

AU - Yager, James D

AU - Zurlo, Joanne

PY - 2012

Y1 - 2012

N2 - The role that in vitro systems can play in toxicological risk assessment is determined by the appropriateness of the chosen methods, with respect to the way in which in vitro data can be extrapolated to the in vivo situation. This report presents the results of a workshop aimed at better defining the use of in vitro-derived biomarkers of toxicity (BoT) and determining the place these data can have in human risk assessment. As a result, a conceptual framework is presented for the incorporation of in vitro-derived toxicity data into the risk assessment process. The selection of BoT takes into account that they need to distinguish adverse and adaptive changes in cells. The framework defines the place of in vitro systems in the context of data on exposure, structural and physico-chemical properties, and toxicodynamic and biokinetic modeling. It outlines the determination of a proper point-of-departure (PoD) for in vitro-in vivo extrapolation, allowing implementation in risk assessment procedures. A BoT will need to take into account both the dynamics and the kinetics of the compound in the in vitro systems. For the implementation of the proposed framework it will be necessary to collect and collate data from existing literature and new in vitro test systems, as well as to categorize biomarkers of toxicity and their relation to pathways-of-toxicity. Moreover, data selection and integration need to be driven by their usefulness in a quantitative in vitro-in vivo extrapolation (QIVIVE).

AB - The role that in vitro systems can play in toxicological risk assessment is determined by the appropriateness of the chosen methods, with respect to the way in which in vitro data can be extrapolated to the in vivo situation. This report presents the results of a workshop aimed at better defining the use of in vitro-derived biomarkers of toxicity (BoT) and determining the place these data can have in human risk assessment. As a result, a conceptual framework is presented for the incorporation of in vitro-derived toxicity data into the risk assessment process. The selection of BoT takes into account that they need to distinguish adverse and adaptive changes in cells. The framework defines the place of in vitro systems in the context of data on exposure, structural and physico-chemical properties, and toxicodynamic and biokinetic modeling. It outlines the determination of a proper point-of-departure (PoD) for in vitro-in vivo extrapolation, allowing implementation in risk assessment procedures. A BoT will need to take into account both the dynamics and the kinetics of the compound in the in vitro systems. For the implementation of the proposed framework it will be necessary to collect and collate data from existing literature and new in vitro test systems, as well as to categorize biomarkers of toxicity and their relation to pathways-of-toxicity. Moreover, data selection and integration need to be driven by their usefulness in a quantitative in vitro-in vivo extrapolation (QIVIVE).

KW - Biomarker of toxicity

KW - Integrated testing strategies

KW - Quantitative in vitro-in vivo extrapolations

UR - http://www.scopus.com/inward/record.url?scp=84871013688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871013688&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 411

EP - 425

JO - ALTEX : Alternativen zu Tierexperimenten

JF - ALTEX : Alternativen zu Tierexperimenten

SN - 1868-596X

IS - 4

ER -